Epilepsy is a chronic neurological disorder that affects over 65 million people worldwide. It is characterized by recurrent seizures that can range from brief and nearly undetectable to long and debilitating. There is no cure for epilepsy, and treatment options are often limited.
Recent studies have shown that mesenchymal stem cells (MSCs) may offer a new treatment option for epilepsy. MSCs are a type of adult stem cell that can be found in many tissues, including the bone marrow. They have the ability to differentiate into different types of cells, including neurons.
MSCs have been shown to be effective in reducing seizure activity in animal models of epilepsy. In one study, MSCs were transplanted into the brains of rats with induced epilepsy. The rats that received MSCs had a significant reduction in seizure activity compared to those that did not receive MSCs.
MSCs may also have other benefits in the treatment of epilepsy. They have been shown to promote the growth of new blood vessels and reduce inflammation. These properties may help to protect the brain from the damage that can be caused by seizures.
The use of MSCs in the treatment of epilepsy is still in the early stages of research. More studies are needed
"Stem Cell Therapy in Treating Epilepsy - Frontiers." 30 May. 2022, https://www.frontiersin.org/articles/10.3389/fnins.2022.934507/full.
"Multipronged Attack of Stem Cell Therapy in Treating the ... - Frontiers." 15 Jan. 2021, https://www.frontiersin.org/articles/10.3389/fphar.2021.596287/full
"The Use of Stem Cell Therapy in Epilepsy." 8 Jun. 2016, https://www.epilepsy.com/stories/use-stem-cell-therapy-epilepsy
The information below is the recommended stem cell therapy protocol for this condition
|Route of Administration